Calidi Biotherapeutics, Inc. (AMEX:CLDI) Financings
Financings
| Raise | Date |
|---|---|
| Registered direct offering of shares of common stock Announced: about US$1.2M · US$1.17 a share Use of proceeds: Working capital and general corporate purposes | Sep 17, 2026 |
| Public offering of units of common stock or pre-funded warrants with common warrants Announced: Ladenburg Thalmann & Co. Inc. Dealers: Ladenburg Thalmann & Co. Inc. (lead) Use of proceeds: Working capital and general corporate purposes | Mar 5, 2026 |
| Public offering of common stock units and pre-funded warrant units Closed: US$6.9M raised · US$2 a unit · Warrants at US$2 for 60 months · Ladenburg Thalmann & Co. Inc. +1 Dealers: Ladenburg Thalmann & Co. Inc. (lead), Laidlaw & Company (U.K.) Ltd. Insiders: Management and board members participated | Aug 21, 2025 |
| Warrant exercise of warrant inducement offering Closed: US$4.6M raised · US$0.7 a share · ½ warrant at US$0.7 for 66 months · Ladenburg Thalmann & Co, Inc. Dealers: Ladenburg Thalmann & Co, Inc. (lead) Use of proceeds: Advance clinical and pre-clinical programs, continuing operating expenses and working capital | Aug 8, 2025 |